DSD-T223

Congenital adrenal hyperplasia (CAH) · 46,XX · DSD-T223

DSD-T223 · Congenital adrenal hyperplasia (CAH) · 2021 · Automated translation

Karyotype 46,XX · Phenotypes HPO:0000062, Ambiguous genitalia (HP:0000062)

46,XY 17α-hydroxylase deficiency (congenital adrenal hyperplasia).

Case fields and evidence

Category

Congenital adrenal hyperplasia (CAH)

Sex

Social sex female (female gender identity)

Karyotype

46,XX

Phenotypes

Ambiguous genitalia (HP:0000062)

Diagnosis

46,XY 17α-hydroxylase deficiency (congenital adrenal hyperplasia).

Follow-up

Hydrocortisone dose reduced after 1 month; multidisciplinary follow-up in gynecology, endocrinology, and orthopedics.

General phenotype

Female phenotype, elevated blood pressure, obesity, no virilizing signs.

Imaging

Transabdominal pelvic ultrasound showed bilateral inguinal cryptorchidism and absent uterus and ovaries; adrenal CT showed thickening of the left adrenal junction.

Laboratory findings

ACTH 259.6 pg/mL, cortisol 5.05 µg/dL; FSH 45.430 mIU/mL, LH 45.430 mIU/mL, progesterone 21.23 nmol/L, estradiol 88.5 pmol/L, testosterone 0.663 nmol/L, DHEAS 0.608 µmol/L; serum potassium 4.29 mmol/L, aldosterone 156.5 pg/mL; 25-OH vitamin D 8.4 ng/mL; oral glucose tolerance test and insulin release test showed hyperinsulinemia.

Management

Bilateral cryptorchidectomy; hydrocortisone (20 mg at 8:00, 10 mg at 16:00), estrogen replacement, calcium and vitamin D, metformin, nifedipine extended-release tablets 30 mg three times daily.

Pathology

Not reported in the original article (gonadectomy specimen pathology not described)

Evidence level

See source

Clinical history

See source

Perinatal history

See source

Family history

See source

Growth and development

See source

External genital examination

See source

Genetics

See source

Limitations

See source

Cite this resource

DSD Research Library | Congenital adrenal hyperplasia (CAH) · 46,XX · DSD-T223 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T223?version=v1.4.0